Effects of bifidobacterial cytoplasm, cell wall and exopolysaccharide on mouse lymphocyte proliferation and cytokine production

被引:51
作者
Amrouche, T
Boutin, Y
Prioult, G
Fliss, I
机构
[1] Univ Laval, Ctr Dairy Res, STELA, Quebec City, PQ G1K 7P4, Canada
[2] Univ Laval, Inst Nutraceut & Funct Foods, INAF, Quebec City, PQ G1K 7P4, Canada
[3] TransBiotech, CEGEP Levis Lauzon, Levis, PQ G6V 9V6, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
bifidobacteria; cell wall; cytokines; cell proliferation; cytoplasm; exopolysaccharides;
D O I
10.1016/j.idairyj.2005.01.008
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Probiotic bifidobacteria have been reported to stimulate the immune system and thus offer the possibility of improving host immune defense against pathogens. The aim of this work was to study the effects of bifidobacterial cytoplasm, cell wall, and exopolysaccha ride (EPS) on splenocyte proliferation and production of -IFN-gamma and IL-10. Three bifidobacteria, RBL64, RBL81, and RBL82 isolated from newborn infant faeces were used in our study. Commercial strain Bifidobacterilan lactis Bb12 was used as a positive control. Among different cell extracts, the cell wall components showed the most profound effects on cell proliferation and cytokine production. EPS neither stimulated lymphocyte proliferation nor induced cytokine secretion. B. lactis Bb12 exhibited a significant immunostimulating effect (stimulation index = 16) compared with other bifidobacteria studied. More-IFN-gamma (> 4ng mL(-1)) was produced in response to cell wall and about 0.8 ngmL(-1) of IL-10 was detected in the cell culture supernatant. The results demonstrate that bifidobacterial extracts, mainly the cell walls, stimulate the proliferation of lymphocytes and suggest that such extracts could be used in controlling certain immune pathologies. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:70 / 80
页数:11
相关论文
共 79 条
[1]   Oral ingestion of lactic-acid bacteria by rats increases lymphocyte proliferation and interferon-γ production [J].
Aattouri, N ;
Bouras, M ;
Tome, D ;
Marcos, A ;
Lemonnier, D .
BRITISH JOURNAL OF NUTRITION, 2002, 87 (04) :367-373
[2]   Probiotic bifidobacteria protect mice from lethal infection with shiga toxin-producing Escherichia coli O157:H7 [J].
Asahara, T ;
Shimizu, K ;
Nomoto, K ;
Hamabata, T ;
Ozawa, A ;
Takeda, Y .
INFECTION AND IMMUNITY, 2004, 72 (04) :2240-2247
[3]   SURFACE-LAYERS OF BACTERIA [J].
BEVERIDGE, TJ ;
GRAHAM, LL .
MICROBIOLOGICAL REVIEWS, 1991, 55 (04) :684-705
[4]   Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology [J].
Bot, A ;
Smith, KA ;
Von Herrath, M .
DNA AND CELL BIOLOGY, 2004, 23 (06) :341-350
[5]   CARBON SOURCE REQUIREMENTS FOR EXOPOLYSACCHARIDE PRODUCTION BY LACTOBACILLUS-CASEI CG11 AND PARTIAL STRUCTURE-ANALYSIS OF THE POLYMER [J].
CERNING, J ;
RENARD, CMGC ;
THIBAULT, JF ;
BOUILLANNE, C ;
LANDON, M ;
DESMAZEAUD, M ;
TOPISIROVIC, L .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1994, 60 (11) :3914-3919
[6]  
Chabot S, 2001, LAIT, V81, P683, DOI 10.1051/lait:2001157
[7]   Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria? [J].
Cross, ML ;
Stevenson, LM ;
Gill, HS .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (05) :891-901
[8]   INTERLEUKIN-10 (IL-10) INHIBITS HUMAN LYMPHOCYTE INTERFERON GAMMA-PRODUCTION BY SUPPRESSING NATURAL-KILLER-CELL STIMULATORY FACTOR/IL-12 SYNTHESIS IN ACCESSORY CELLS [J].
DANDREA, A ;
ASTEAMEZAGA, M ;
VALIANTE, NM ;
MA, XJ ;
KUBIN, M ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :1041-1048
[9]  
de Roos NM, 2000, AM J CLIN NUTR, V71, P405
[10]  
DESIMONE C, 1993, INT J IMMUNOTHER, V9, P23